Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junan Li

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Frontiers in Pharmacology|January 23, 2024
<i>CYP3A5</i> influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantationNathan D Seligson, Xunjie Zhang, Mark C Zemanek, et al.
Molecular Carcinogenesis|September 24, 2019
XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplantAvinash K Persaud, Junan Li, Jasmine A Johnson, et al.
Research Square|August 7, 2023
CYP5122A1 encodes an essential sterol C4-methyl oxidase in <i>Leishmania donovani</i> and determines the antileishmanial activity of antifungal azolesYiru Jin, Somrita Basu, Mei Feng, et al.
Leukemia & Lymphoma|May 17, 2017
G-CSF improves safety when you start the day after autologous transplant in multiple myelomaDouglas W Sborov, Yu Kyoung Cho, Francesca Cottini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 10, 2023
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 MiceYang Li, Yasuhiro Kazuki, Thomas Drabison, et al.
Haematologica|March 2, 2023
<i>PARP1</i> and <i>POLD2</i> as prognostic biomarkers for multiple myeloma in autologous stem cell transplantMelissa Thomas, Junan Li, Kevan King, et al.
Clinical Breast Cancer|August 28, 2019
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, M Alexandra Schickli, Michael J Berger, et al.
ACS Infectious Diseases|February 4, 2021
Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl LinkerAhmed Abdelhameed, Mei Feng, April C Joice, et al.
Nature Communications|December 15, 2021
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapyWenqing Li, Xinfu Zhang, Chengxiang Zhang, et al.
Leukemia & Lymphoma|February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experienceFiliz Yucebay, Christina Matthews, Marcin Puto, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|January 23, 2024
<i>CYP3A5</i> influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantationNathan D Seligson, Xunjie Zhang, Mark C Zemanek, et al.
Molecular Carcinogenesis|September 24, 2019
XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplantAvinash K Persaud, Junan Li, Jasmine A Johnson, et al.
Research Square|August 7, 2023
CYP5122A1 encodes an essential sterol C4-methyl oxidase in <i>Leishmania donovani</i> and determines the antileishmanial activity of antifungal azolesYiru Jin, Somrita Basu, Mei Feng, et al.
Leukemia & Lymphoma|May 17, 2017
G-CSF improves safety when you start the day after autologous transplant in multiple myelomaDouglas W Sborov, Yu Kyoung Cho, Francesca Cottini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 10, 2023
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 MiceYang Li, Yasuhiro Kazuki, Thomas Drabison, et al.
Haematologica|March 2, 2023
<i>PARP1</i> and <i>POLD2</i> as prognostic biomarkers for multiple myeloma in autologous stem cell transplantMelissa Thomas, Junan Li, Kevan King, et al.
Clinical Breast Cancer|August 28, 2019
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, M Alexandra Schickli, Michael J Berger, et al.
ACS Infectious Diseases|February 4, 2021
Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl LinkerAhmed Abdelhameed, Mei Feng, April C Joice, et al.
Nature Communications|December 15, 2021
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapyWenqing Li, Xinfu Zhang, Chengxiang Zhang, et al.
Leukemia & Lymphoma|February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experienceFiliz Yucebay, Christina Matthews, Marcin Puto, et al.
Pageof 12